Open AccessEvaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020)
Author(s) -
Cecília G Carvalhaes,
Abby L Klauer,
Paul R. Rhomberg,
Michael A. Pfaller,
Mariana Castanheira
Publication year - 2022
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.02449-21
Subject(s) - microbiology and biotechnology , candida glabrata , candida krusei , candida parapsilosis , broth microdilution , biology , candida tropicalis , echinocandins , candida albicans , echinocandin , candida dubliniensis , corpus albicans , minimum inhibitory concentration , fluconazole , antibiotics , caspofungin , antifungal
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom